Absence of prohibitin gene mutations in human epithelial ovarian tumors

William Arthur Cliby, G. Sarkar, S. R. Ritland, L. Hartmann, K. C. Podratz, Robert Brian Jenkins

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Multiple loss of heterozygosity (LOH) studies of ovarian cancers have found a high incidence of chromosome 17 loss in these tumors. Several authors have suggested that the region commonly deleted encompasses 17q12-21. In addition, this region has recently been reported to be linked to the familial breast/ovarian cancer syndrome. Recently the human prohibitin gene was mapped to region 17q12-22. Prohibitin causes arrest of DNA synthesis by fibroblast and HeLa cells and prohibitin shows significant homology to a gene (Cc) thought to be important for the regulation of development of Drosophila melanogaster. These findings have led many to consider the prohibitin gene a potential tumor suppressor gene. In addition, sequence analysis of exon 4 of human prohibitin gene revealed mutations in 4 of 23 sporadic breast carcinomas. Because of the proposed function for prohibitin, its alterations in breast cancers, and the fact that its location on 17q falls within a commonly deleted region in ovarian cancers, we have undertaken an analysis of the sequence of prohibitin in epithelial ovarian cancers. Using several polymorphic DNA probes, we identified 20 epithelial ovarian tumors which demonstrated LOH for the region that contains the prohibitin gene. To evaluate whether mutations of prohibitin may be important in ovarian carcinogenesis, we have sequenced exons 4 and 5 of this gene using the technique of genomic amplification with transcript sequencing. Only normal exon 4 and 5 sequence was observed among the 20 tumors screened. These results demonstrate that this region of the prohibitin gene is not mutated in epithelial ovarian cancers and suggest that the prohibitin gene does not play a role in ovarian carcinogenesis. Sequencing of further exons and introns are needed to confirm this latter hypothesis.

Original languageEnglish (US)
Pages (from-to)34-37
Number of pages4
JournalGynecologic Oncology
Volume50
Issue number1
DOIs
StatePublished - 1993

Fingerprint

Mutation
Genes
Neoplasms
Exons
Ovarian Neoplasms
Loss of Heterozygosity
Sequence Analysis
Carcinogenesis
prohibitin
Breast Neoplasms
Chromosomes, Human, Pair 17
DNA Probes
Tumor Suppressor Genes
Drosophila melanogaster
HeLa Cells
Introns
Fibroblasts
DNA
Incidence

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Absence of prohibitin gene mutations in human epithelial ovarian tumors. / Cliby, William Arthur; Sarkar, G.; Ritland, S. R.; Hartmann, L.; Podratz, K. C.; Jenkins, Robert Brian.

In: Gynecologic Oncology, Vol. 50, No. 1, 1993, p. 34-37.

Research output: Contribution to journalArticle

Cliby, William Arthur ; Sarkar, G. ; Ritland, S. R. ; Hartmann, L. ; Podratz, K. C. ; Jenkins, Robert Brian. / Absence of prohibitin gene mutations in human epithelial ovarian tumors. In: Gynecologic Oncology. 1993 ; Vol. 50, No. 1. pp. 34-37.
@article{dbe518ada3e24a5a801c51a0c17ae183,
title = "Absence of prohibitin gene mutations in human epithelial ovarian tumors",
abstract = "Multiple loss of heterozygosity (LOH) studies of ovarian cancers have found a high incidence of chromosome 17 loss in these tumors. Several authors have suggested that the region commonly deleted encompasses 17q12-21. In addition, this region has recently been reported to be linked to the familial breast/ovarian cancer syndrome. Recently the human prohibitin gene was mapped to region 17q12-22. Prohibitin causes arrest of DNA synthesis by fibroblast and HeLa cells and prohibitin shows significant homology to a gene (Cc) thought to be important for the regulation of development of Drosophila melanogaster. These findings have led many to consider the prohibitin gene a potential tumor suppressor gene. In addition, sequence analysis of exon 4 of human prohibitin gene revealed mutations in 4 of 23 sporadic breast carcinomas. Because of the proposed function for prohibitin, its alterations in breast cancers, and the fact that its location on 17q falls within a commonly deleted region in ovarian cancers, we have undertaken an analysis of the sequence of prohibitin in epithelial ovarian cancers. Using several polymorphic DNA probes, we identified 20 epithelial ovarian tumors which demonstrated LOH for the region that contains the prohibitin gene. To evaluate whether mutations of prohibitin may be important in ovarian carcinogenesis, we have sequenced exons 4 and 5 of this gene using the technique of genomic amplification with transcript sequencing. Only normal exon 4 and 5 sequence was observed among the 20 tumors screened. These results demonstrate that this region of the prohibitin gene is not mutated in epithelial ovarian cancers and suggest that the prohibitin gene does not play a role in ovarian carcinogenesis. Sequencing of further exons and introns are needed to confirm this latter hypothesis.",
author = "Cliby, {William Arthur} and G. Sarkar and Ritland, {S. R.} and L. Hartmann and Podratz, {K. C.} and Jenkins, {Robert Brian}",
year = "1993",
doi = "10.1006/gyno.1993.1160",
language = "English (US)",
volume = "50",
pages = "34--37",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Absence of prohibitin gene mutations in human epithelial ovarian tumors

AU - Cliby, William Arthur

AU - Sarkar, G.

AU - Ritland, S. R.

AU - Hartmann, L.

AU - Podratz, K. C.

AU - Jenkins, Robert Brian

PY - 1993

Y1 - 1993

N2 - Multiple loss of heterozygosity (LOH) studies of ovarian cancers have found a high incidence of chromosome 17 loss in these tumors. Several authors have suggested that the region commonly deleted encompasses 17q12-21. In addition, this region has recently been reported to be linked to the familial breast/ovarian cancer syndrome. Recently the human prohibitin gene was mapped to region 17q12-22. Prohibitin causes arrest of DNA synthesis by fibroblast and HeLa cells and prohibitin shows significant homology to a gene (Cc) thought to be important for the regulation of development of Drosophila melanogaster. These findings have led many to consider the prohibitin gene a potential tumor suppressor gene. In addition, sequence analysis of exon 4 of human prohibitin gene revealed mutations in 4 of 23 sporadic breast carcinomas. Because of the proposed function for prohibitin, its alterations in breast cancers, and the fact that its location on 17q falls within a commonly deleted region in ovarian cancers, we have undertaken an analysis of the sequence of prohibitin in epithelial ovarian cancers. Using several polymorphic DNA probes, we identified 20 epithelial ovarian tumors which demonstrated LOH for the region that contains the prohibitin gene. To evaluate whether mutations of prohibitin may be important in ovarian carcinogenesis, we have sequenced exons 4 and 5 of this gene using the technique of genomic amplification with transcript sequencing. Only normal exon 4 and 5 sequence was observed among the 20 tumors screened. These results demonstrate that this region of the prohibitin gene is not mutated in epithelial ovarian cancers and suggest that the prohibitin gene does not play a role in ovarian carcinogenesis. Sequencing of further exons and introns are needed to confirm this latter hypothesis.

AB - Multiple loss of heterozygosity (LOH) studies of ovarian cancers have found a high incidence of chromosome 17 loss in these tumors. Several authors have suggested that the region commonly deleted encompasses 17q12-21. In addition, this region has recently been reported to be linked to the familial breast/ovarian cancer syndrome. Recently the human prohibitin gene was mapped to region 17q12-22. Prohibitin causes arrest of DNA synthesis by fibroblast and HeLa cells and prohibitin shows significant homology to a gene (Cc) thought to be important for the regulation of development of Drosophila melanogaster. These findings have led many to consider the prohibitin gene a potential tumor suppressor gene. In addition, sequence analysis of exon 4 of human prohibitin gene revealed mutations in 4 of 23 sporadic breast carcinomas. Because of the proposed function for prohibitin, its alterations in breast cancers, and the fact that its location on 17q falls within a commonly deleted region in ovarian cancers, we have undertaken an analysis of the sequence of prohibitin in epithelial ovarian cancers. Using several polymorphic DNA probes, we identified 20 epithelial ovarian tumors which demonstrated LOH for the region that contains the prohibitin gene. To evaluate whether mutations of prohibitin may be important in ovarian carcinogenesis, we have sequenced exons 4 and 5 of this gene using the technique of genomic amplification with transcript sequencing. Only normal exon 4 and 5 sequence was observed among the 20 tumors screened. These results demonstrate that this region of the prohibitin gene is not mutated in epithelial ovarian cancers and suggest that the prohibitin gene does not play a role in ovarian carcinogenesis. Sequencing of further exons and introns are needed to confirm this latter hypothesis.

UR - http://www.scopus.com/inward/record.url?scp=0027163687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027163687&partnerID=8YFLogxK

U2 - 10.1006/gyno.1993.1160

DO - 10.1006/gyno.1993.1160

M3 - Article

C2 - 8349162

AN - SCOPUS:0027163687

VL - 50

SP - 34

EP - 37

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -